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Single-cell characterisation and rapid enumeration of E. coli was achieved by confining 
them into the picoliter droplets of a water-in-oil fuorinated emulsion. 
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Abstract 
Today, rapid detection and identification of bacteria in microbiological diagnosis is a major 
issue. Reference methods usually rely on growth of micro-organisms, with the drawback of 
lengthy time-to-result. The method provides global information on a clonal population that is 
known to be inhomogeneous relative to metabolic states and activities. Therefore, there may 
be a significant advantage of methods that allow characterization of individual bacteria from a 
large population, both for test time reduction and the clinical value of the characterization. We 
report here a method for rapid detection and real-time monitoring of the metabolic activities 
of single bacteria. Water-in-oil emulsions were used to encapsulate single Escherichia coli 
cells into picolitre (pL)-sized microreactor droplets. The glucuronidase activity in each 
droplet was monitored using the fluorogenic reporter molecule MUG (4-Methylumbelliferyl 
β-D-glucuronide) coupled to time-lapse fluorescence imaging of the droplets. Such bacterial 
confinement provides several major advantages. 
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1) Enzymatic activities of a large number of single bacterium-containing droplet could be 
monitored simultaneously, allowing the full characterization of metabolic heterogeneity in a 
clonal population. We monitored glucuronidase enzymatic activity and growth over ~200 
single bacteria over a 24h-period. 
2) Micro-confinement of cells in small volumes allows rapid accumulation of the fluorescent 
metabolite, hence decreasing the detection time. Independent of the initial concentration of 
bacteria in the sample, detection of the presence of bacteria could be achieved in less than two 
hours. 
3) Considering the random distribution of bacteria in droplets, this method allowed rapid and 
reliable enumeration of bacteria in the initial sample.  
Overall, the results of this study showed that confinement of bacterial cells increased the 
effective concentration of fluorescent metabolites leading to rapid (2 h) detection of the 
fluorescent metabolites, thus significantly reducing time to numeration. 
Keywords 
w/o emulsion; bacteria encapsulation; bacteria enumeration; fluorosurfactant; single-cell 
characterisation; microdroplets 
1. Introduction 
There is a growing interest in encapsulation of cells into water-in-oil (w/o) emulsion as this 
way of compartmentalisation of an aqueous solution provides numerous microreactors, each 
allowing simultaneous biochemical reactions to be monitored. 1,2,3,4 Every droplet is a pL-
scale microvessel and the continuous phase, the oil, is both a drop carrier and a barrier against 
cross-contamination between drops (referred to as In Vitro Compartmentalisation, IVC). That 
is why these w/o emulsions are considered a powerful tool to perform high-throughput 
screening. 5 Aqueous microdroplets are also useful to conduct biological assays on single 
cells. During emulsification of a diluted suspension of cells, the majority of drops formed are 
empty with a low fraction of drops that are filled with one cell. This process is called 
stochastic confinement since the filling of a droplet during emulsification is random. 6,7,8,9 
This technique has allowed, for example, the study of the high-density communication 
behaviour ('quorum sensing') of a few bacteria, without influence from host factors. 10 In 
another example, it has enabled the simultaneous determination of gene expression and 
enzymatic activity in single bacteria. 11 
 Studies of stochastic confinement, may also lead to applications in the field of in-vitro 
diagnostic. For example, antibiotic susceptibility testing on single bacteria confined in 
nanolitre (nL) droplets has been recently reported. 12 Such an approach was faster compared 
with the conventional test for two reasons. First, by testing individual cells, an amplification 
step normally associated with conventional bacterial culture was not required before 
susceptibility testing. Secondly, micro-confinement allowed faster accumulation of 
fluorescent metabolites, hence reducing detection time and yielding a faster result about 
susceptibility. 
 Foodborne diseases continue to be significant causes of illness and death worldwide, it 
is therefore important to improve diagnostic tests for the detection and numeration of 
foodborne pathogens. Many of the tests are based on chromogenic or fluorogenic enzyme 
substrates. 13 To date, attempts to reduce the assay time for the detection and enumeration 
have been impeded by the necessity to incubate the bacterial specimens for a few hours to 
days, in order to increase the cell density in samples to detectable levels. Single-cell analysis 
is expected to considerably decrease the time-to-result. The purpose of the present study was 
to monitor the enzymatic activity of single bacteria confined in micro-volumes using 
fluorescence microscopy over a 24-h period. 
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2. Material and methods 
2.1 Microfluidic device fabrication 
MFFD (Microfluidic Flow Focusing Devices) are made of polydimethylsiloxane (PDMS) 
using conventional soft lithographic techniques. 14 Briefly, a master was prepared from 
Ordyl®, a commercially available thick resist film (50 µm), patterned with standard 
photolithography process on a silicon substrate. Silicone elastomer (sylgard 184, Dow 
Corning) was mixed in a 5:1 (w/w) ratio of resin to crosslinker and then poured over the 
master. After degassing, devices are cured for one hour at 65°C. The cured PDMS is then 
peeled off the master. Access holes for fluidic tubing are created using a needle. Microfluidic 
chips are sealed with a PDMS cover using O2 plasma and are baked at 65 °C for 4 hours. 
Channels are made hydrophobic by silanisation so as to obtain the formation of aqueous 
droplets in a continuous oil phase. 
2.2 Synthesis of emulsifying agent 
The emulsifying agent DMP-PFPE (dimorpholinophosphinate perfluoropolyether) was 
prepared in a three step process: the synthesis of the hydrophilic head dimorpholinophosphate, 
the preparation of the fluorophilic tail perfluoropolyether and finally the coupling between the 
DMP head and the PFPE tail. 
2.2.1 Phenethyl dimorpholinophosphinate 
In a 500 mL three-necked flask under nitrogen, dry diethyl ether (150 mL) and POCl3 (7.8 
mL, 1.003 eq) were introduced successively at room temperature. The flask was cooled to 
0°C. Then a solution of phenethyl alcohol (10 mL, 1 eq) and triethylamine (29 mL, 2.5 eq) in 
dry diethyl ether (110 mL) was added dropwise at 0°C in 30’. Stirring was maintained for 1h. 
Then a solution of morpholine (14.7 mL, 2 eq) and triethylamine (60 mL, 5 eq) in dry diethyl 
ether (110 mL) was added dropwise at 0°C in 30’. The mixture was stirred overnight at room 
temperature. The solid was filtered off and washed with diethyl ether. The resulting filtrate 
was evaporated under vacuum, which yields 27.4 g of translucent oil. The crude oil was 
purified by column chromatography (silicagel, ethyl acetate/MeOH 9/1). After this 
purification step, we obtained 25.3 g of pure phosphinate as a translucent oil (yield=89%). 
• Thin-Layer Chromatography on silicagel, ethyl acetate:methanol 9:1 : Rf= 0.2 
• Nuclear Magnetic Resonance 1H (300 MHz, CDCl3) : 3.04 (10H, m), 3.51 (8H, m), 4.16 
(2H, m), 7.26 (5H, m) ppm. 
2.2.2 PFPE acyl chloride 
In a 250 mL round bottom flask, Krytox 157 FSM (50 g, 1 eq) and perfluoromethyl 
cyclohexane (50 g) and dimethylformamide (1 mL) were added. The resulting mixture was 
refluxed and SOCl2 (1.5 mL, 1.65 eq) was added dropwise. The reaction mixture became 
white and then was refluxed overnight. The resulting biphasic mixture was decanted and the 
dark phase was removed. The white phase was evaporated under vacuum at 60 °C, until no 
more distillate is obtained. The crude PFPE acyl chloride (50 g) was used without further 
purification in the next step. 
2.2.3 DMP-PFPE 
The phenethyl dimorpholinophosphinate that is obtained in step 1 (17 g, 4 eq) is mixed with 
the crude PFPE acyl chloride (50 g) and finely powdered aluminium chloride (2.5 g, 1.5 eq). 
The thick mixture was mechanically stirred and heated at 70 °C overnight. The semi-solid 
gum was cooled to room temperature and stirred with water (1 L). Then NaOH 1 N was added 
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until pH became basic. The resulting mixture was stirred for 1h. The aqueous phase was 
removed and the gum was washed with water (2x1 L) and methanol (2x1 L). The resulting 
beige gum was dried under high vacuum for 4 days, so as to yield a semi-solid beige gum (40 
g). 
Nuclear Magnetic Resonance 13C (400 MHz, HRMAS, s=3 kHz) : 45.3(brs), 47.6(brs), 
66.8(brs), 102.3(m), 104.9(m), 114.0(m), 117.0(m), 119.9(m), 122.7(d), 157.0(brs) ppm. 
2.3 Bacterial cell culture 
The Escherichia coli strain we used was E. coli BL21-Codon Plus-RIL Competent Cells 
(Stratagen, ref. 230240). Cells were transformed with the plasmid pDsRed Express (Becton 
Dickinson, ref. 632412). This plasmid codes for DsRed fluorescent protein (excitation: 557 
nm; emission: 579 nm) and provides ampicillin resistance through β-lactamase expression. 
 After a preculture phase overnight (17h at 30°C without stirring) in Lysogenic Broth 
(LB medium Lennox, Q-Biogene) with ampicillin (100 mg/L), cell concentration was 
adjusted to OD550 = 0.7 (Optical Density at 550 nm). Then 4 mL of LB medium supplemented 
with 100 mg/L ampicillin was inoculated at 1/50 dilution with precultured bacteria (80 µL of 
preculture medium) prior to incubation at 37°C with stirring at 250 rpm. After this step, the 
measured OD550 of the culture was 0.278, corresponding to 5.6×107 cfu/mL (2.107 cfu/mL for 
0.1 OD550 was demonstrated using the growth medium used in the study, data not shown). 
Bacteria from this culture were then diluted in fluorogenic culture medium (dilution factor of 
1/556), so as to obtain a theoretical 105 cfu/mL suspension in the fluorogenic medium. The 
time of this dilution (and medium transfer) was set as t=0 time of the enzymatic assay in all 
experiments. As a control, part of this suspension was also immediately spread on chromID 
CPS3 (bioMérieux) and LB agar plates (LB agar Lennox, Q-Biogene), in order to measure the 
bacterial concentration at t=0 according to the standard enumeration method. 
 Rapid methods for the detection of E. coli and coliforms are based on the assumption 
that β-D-glucuronidase and β-D-galactosidase are markers for E. coli and coliforms 
respectively. 15 Our fluorogenic culture medium contains substrate for β-D-glucuronidase 
(Fig. 1a) and was optimised so as to increase the glucuronidase activity. It also contains a pH 
stabilisation buffer, so as not to alterate the fluorescence of fluorescein and 4-MU that are pH-
dependant. The composition of this medium is MOPS (4-Morpholinepropanesulfonic acid 
sodium salt) 150 mM; magnesium sulfate 2,6 mM; sodium glucuronate 854 µM; methyl β-D-
glucuronide 870 µM; MUG (4-methylumbelliferyl-β-D-glucuronide) 113 µM; fluorescein 
4.15 µM; ampicillin 100 mg/L. The pH buffer is 7.33. 
2.4 Bacteria encapsulation and enzymatic assay 
Aqueous droplets are formed using a Microfluidic Flow Focusing Device (MFFD). 16,17 The 
geometry is that of a conventional MFFD, except the triangular chamber downstream of the 
nozzle (Fig. 1b). This triangular enlargement has been proposed by Tan et al. 18 to focus the 
velocity gradient at the nozzle. 
 The movement of oil and aqueous solution is controlled using a pressure-based flow 
control system (Fluigent® MFCS-8C-1000 mbar). All the pressures reported are relative to 
atmosphere. The oil phase is a solution of DMP-PFPE fluorosurfactant at 5%w/w in 
perfluorotripentylamine (Fluorinert FC-70, 3M Corp.). The aqueous phase is the 105 cfu/mL 
of E. coli in the fluorogenic medium. Relative pressures are adjusted to get a droplet 
formation frequency of dozens of drops per second. 
 The formed droplets have a mean diameter of 73 µm (σ=7 µm) and a mean volume of 
210 pL (σ=70 pL). They are stored as a monolayer in a buffer tank covered with a 73×26 mm 
microscope glass slide (0.17 mm thick). When the buffer tank is filled with droplets, driving 
pressure is immediately stopped, to stop emulsification process. It takes 1h45 minutes to fill 
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the tank. If bacteria are diluted enough in the aqueous phase to be divided, we can neglect the 
fluorescence increase that may occur for some drops between t=0 and the moment of the 
encapsulation in the MFFD. After filling the buffer tank, the monitoring of fluorescence starts 
on 56 microscope fields chosen in the areas presenting a high density of droplets (as shown in 
Fig. 1c). Every selected field is observed every hour, from t=2 h to t=22 h, in order to 
measure the fluorescence intensities of fluorescein, DsRed protein and 4-MU. These 
observations are made with an Axio Imager microscope (Zeiss) using a 10× objective (0.17 
mm cover glass correction, NA 0.5). 
 Since the cell density c of the aqueous phase at t=0 is 105 cfu/mL, namely c=0.1 
cfu/nL, we can consider that all the filled droplets contain no more than a single bacterium. 
Indeed, a majority of droplets have a volume V=200 pL. Therefore we obtain a mean 
occupancy cV of 0.02, and we infer from Poissonian statistics p(x)=(cV)xe-cV/x! that the single, 
double and triple occupancies are p(1)=0.2 %, p(2)=2.10-4 % and p(3)=2.10-7 %, respectively. 
Single occupancy at t=0 simplifies the interpretation but is not a limitation of the enumeration 
method. 
3. Results and discussion 
3.1 Emulsion formulation 
The emulsion formulation is of critical importance to provide efficient IVC. The choice of the 
oil phase and emulsifying agent was determined by the following considerations. 
 Continuous phase has to fulfil a number of requirements. It has to be an efficient 
impediment to diffusion between droplets. Its viscosity must be high enough to enable the 
formation of droplets through shear stress, but not too excessive to avoid huge pressure drops 
in fluidic systems. 19 Continuous phase has to allow for the exchange of gases, especially 
when an aerobic strain is encapsulated. So an oil with good solubility for gases is preferred. 
Finally, oil has to be biocompatible and therefore it must be a poor solvent: molecules that 
would dissolve some components of the bacterial membrane are not adapted (such as toluene 
20
 for example). 
 Continuous phase can be chosen among the most common groups of oils: fatty acid 
esters (isopropyle palmitate, cetearyl isononanoate, etc.), mineral oils (paraffinic oils, 
naphthenic oils, etc.), heavy alcohols and long fatty acids (decanol, oleic acid, etc.), vegetable 
oils (soybean oil, castor oil, etc.), silicone oils (hexadimethylsiloxane, dimethicon, etc.) and 
fluorinated oils (perfluorodecalin, perfluorotributylamine FC-43, etc.). In particular, silicone 
and fluorinated oils are particular since they are simultaneously hydrophobic and lipophobic. 
They are consequently the most adapted continuous phases for IVC experiments. 
Furthermore, they both show good solubilities for gases. For example, oxygen is at least ten 
times as soluble in silicone oil (polydimethylsiloxan at 1 centistoke) as in plasma or saline. 
Previous studies have reported that goldfish had survived under such an oil for several weeks. 
21
 The solubility of gases is even higher in perfluorinated liquids, such as FX-80 (perfluoro-2-
butyltetrahydrofuran) and perflubron (perfluorooctyl bromide), and, thus, have been studied 
since the sixties for partial liquid ventilation (administrated to premature infants for example), 
22
 or as blood substitutes. 23,24 The solubility of oxygen in this kind of liquids is typically 35-
44 mmol/L (2.2 mmol/L in water), and more than 200 mmol/L for carbon dioxide. 25 In 
literature, perfluorinated liquids are more frequently used in IVC than silicone oils. Indeed, 
fluorinated oils are more efficient than silicone oils to prevent cross-contamination between 
droplets. Nevertheless, the suspected toxicity and the strong remanence of perfluorinated 
compounds 26 require circumspection today regarding the common use of perfluorinated oils. 
A recent paper by Courtois et al. 27 proposed an interesting alternative to fluorinated 
continuous phases in the field of IVC: the addition of amphiphilic protein BSA (bovine serum 
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albumin) substantially reduced leaking of the fluorophore into the oil phase (mineral oil). In 
our study, we focused our formulation trials on silicone oil AR-20 (polyphenyl-
methylsiloxane, 20 mPa.s) and on fluorinated oil FC-70 (perfluorotripentylamine, 27 mPa.s). 
 Since we want to stabilise a w/o emulsion, the emulsifying agent has to be an 
amphiphilic molecule that shows more affinity with continuous phase than with dispersed 
phase (Bancroft's rule). In terms of hydrophilic-lipophilic balance (HLB), we need low HLB 
surfactants. 28 Ideally, this surfactant should be soluble in the oil phase, but not in water. 
Secondly, in order to impede the coalescence of adjacent droplets, it is better to use 
surfactants showing slow exchange kinetics between interfacial zone and the two phases 
(continuous and dispersed). That is why amphiphilic polymers are often used as emulsifying 
agents. A silicone oil necessitates a silicophilic/hydrophilic polymer, such as Abil EM-90 
(Cetyl PEG/PPG-10/1 Dimethicone), 29,30 whereas a fluorinated continuous phase requires a 
fluorophilic/hydrophilic molecule, such as a PFPE-PEG block copolymer (perfluoropolyether-
polyethylene glycol). 31 Regarding biocompatibility, a non-hydrosoluble emulsifying agent is 
also most suitable to prevent contact of the cells with surfactants. Moreover, the charged 
headgroups of surfactants may interact with charged biomolecules and result in their 
denaturation. 32 For example, the cationic surfactant CTAB (cetyltrimethylammonium 
bromide) has a lethal effect, not only on bacterial species, such as Bacillus subtilis and 
Pseudomonas aeruginosa, 33 but also on eukaryotic cells, such as Saccharomyces cerevisiae. 
34
 The antibacterial effect of an anionic surfactant like SDS (sodium dodecyl sulfate) has also 
been reported. 35 On the contrary, the toxicity of neutral surfactants is considerably lower. 36 
As a conclusion, bacterial encapsulation into w/o emulsions requires emulsifying agents with 
non-ionic hydrophilic headgroups. Regarding silicone oils, many surfactants that fulfil this 
requirement are commercially available, such as Abil EM-90 (Sunjin Chemical Co.), DC-
5225C (Dow Corning) or KF-6017 (Sunjin Chemical Co.). In contrast, the choice of 
commercially available fluorosurfactants that stabilise water-in-oil emulsions is strongly 
limited. Indeed, most of fluorosurfactants have been designed to stabilise direct emulsions and 
are thus too much hydrophilic, such as Zonyl molecules (DuPont). Recent publications have 
reported the synthesis and the use of new fluorosurfactants in droplet compartmentalisation, 
31,37,38,39 like DMP-PFPE, PEG-PFPE or poly-L-lysine-PFPE (DMP: dimorpholinophosphate, 
PEG: polyethylene glycol, PFPE: perfluoropolyether). 
 We finally chose to try two formulations: a silicone one, Abil EM-90 (emulsifying 
agent) dissolved in polyphenyl-methylsiloxane AR-20 (oil), and a fluorinated one, DMP-
PFPE (emulsifying agent) dissolved in Fluorinert FC-70 (perfluorotripentylamine, oil). As a 
first step, we prepared a w/o emulsion (10%v/v water) with a solution of Abil EM-90 in AR-
20 silicone oil at 0.1%w/w as a continuous phase. The dispersed phase was an aqueous 
suspension of E. coli in our fluorogenic buffer at 3.6×107 cfu/mL. This formulation was not 
toxic for bacteria since we observed cell divisions in the first 24 h (data not shown). However, 
it did not fulfil the IVC requirements since it does not prevent diffusion between droplets. 
This solute transfer is called compositional ripening and originates in the fact that the 
equilibrium state is an emulsion in which every droplet has the same chemical composition. 
40,41
 As a consequence, this ripening starts as soon as bacteria degrade MUG enzymatic 
substrate: 4-MU fluorophore diffuses from the drops containing cells to the empty droplets. 
Alternatively, a flow of MUG takes place from the empty droplets to the filled ones. In the 
case of silicone formulation, we observed a massive transfer of 4-MU fluorophore in less than 
3 hours after emulsification, so that the 4-MU concentration was the same throughout the 
whole dispersed phase (data not shown). 
 The solute transfer through the continuous phase is reported as a molecular transport 
in which the surfactant micelles present in the oil act as carriers for droplet solutes. 40,42 
Owing to this "micelle carrier mechanism", a way of hindering compositional ripening is to 
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use emulsifying agents with a high CMC (critical micellar concentration) and to use a 
surfactant concentration as low as possible. Alternate solutions include the addition of an 
amphiphilic macromolecule (such as BSA), 27 that adsorb at the drop interface or the use of a 
fluorinated oil. We chose to encapsulate bacteria into fluorinated w/o emulsions, as reported 
by Clausell-Tormos et al., 37 with a solution of DMP-PFPE in FC-70 at 5%w/w as a 
continuous phase. 
 Another type of mass transfer is also usually observed: Ostwald ripening, which is the 
diffusion of the dispersed phase material, water in our case, from smaller droplets to larger 
ones. This water transportation is caused by the difference in curvature radius of the dispersed 
phase droplets, and consequently, the difference in chemical potential of substances within the 
droplets. 43 As a result, small droplets become smaller and large droplets become larger, 
leading to droplet size growth and interfacial area reduction. Ostwald ripening rate depends 
on the average radius of droplets and ripening slows down when drops get larger. That is why, 
as the Lifshitz-Slezov-Wagner (LSW) model shows, this phenomenon is much slower for 
micrometric drops. 44 According to LSW equation, for micrometer-sized drops, the diameter 
increase is not measurable over a few hours time scale. In our experiments, we compared the 
size distributions of droplets between the beginning and the end of incubation, and no Oswald 
ripening was observed. 
3.2 Monitoring of enzymatic activity 
Three fluorescence intensities were measured in this study, as shown in Fig. 2: fluorescein, 
DsRed and 4-MU. The first two intensities are reference signals that could be suppressed in 
an enzymatic assay. All three of them are monitored from t=2 h to t= 22 h (Fig. 3 and Fig. 4). 
 Fluorescein is the reference fluorophore. Indeed, its concentration is constant versus 
time since it is not produced in situ like 4-MU. Furthermore, its concentration is the same in 
every droplet and therefore it is not subject to compositional ripening. Fig. 4a plots the 
fluorescence intensity of fluorescein as a function of time, between t=2 h and t=22 h, for the 
six droplets delineated in Fig. 2d. Fluorescein is not required if droplets are monodisperse: it 
becomes essential to normalise fluorescence signals when diameter distribution gets wider. 
Finally, fluorescein can be used as a fluorescent probe for pH measurements, since its 
fluorescence depends on pH (pKA 2.2; 4.4; 6.4). 45 Therefore, our results from Fig. 4a show 
that pH is stable within droplets during incubation, thanks to MOPS buffer (150 mM). Such a 
conclusion is important since 4-MU fluorescence also depends on pH. 
 The DsRed protein enables a straightforward distinction between full droplets, i.e. 
those that include at least one bacterium at t=0, and empty droplets, namely without bacterial 
cells (see Fig. 2b). In the same way as mRFP labelling protein, 46 the fluorescence of DsRed is 
confined in the cells since it does not cross bacterial membrane. 47 DsRed also reveals the 
division of bacteria after encapsulation into drops. As seen in Fig. 2b, confined E. coli have 
already divided at t=8 h. We have noticed that one to two divisions happened before t=4 h in 
the majority of full droplets. This observation is in accordance with the generation time we 
measured in our fluorogenic nutrition medium (approximately 2 hours, data not shown) and 
reveals the biocompatibility of the chosen formulation. In order to quantify the growth inside 
drops, the fluorescence intensity of DsRed protein was normalised against fluorescein. Based 
on this normalisation, we can take into account the volume differences between droplets, as 
well as the slight illumination heterogeneities. As illustrated in Fig. 4b, DsRed fluorescence 
allows an easy distinction between empty and filled droplets: the empty droplet, number 6, 
presents a low and constant normalised fluorescence, whereas the other five drops, which are 
full, exhibit an increase and then variations of fluorescence due to field depth. E. coli cells 
tend to move inside droplets, hence focus might be lost at times, causing the measured DsRed 
fluorescence to decrease. That is why we decided to consider the maximum of the normalised 
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DsRed fluorescence in order to make the distinction between full and empty droplets. This 
sorting yielded 214 full droplets among the 3902 droplets we studied in the 56 selected 
microscope fields. 
 The 4-MU is produced inside bacterial cells through the glucuronidase activity and is 
then released within the droplets since it permeates through bacterial membranes. As a 
consequence, a droplet filled with a bacterium shows higher 4-MU fluorescence intensity than 
its adjacent empty drops. The phenomenon of compositional ripening causes a mass transfer 
of the 4-MU aqueous solute from a filled droplet to the adjacent empty ones, as illustrated in 
Fig. 3. It is worth noting the low probability of finding two adjacent filled droplets (0.3%), 
since the occupancy rate is rather low. Therefore, the 4-MU fluorescence we can measure 
around a filled drop cannot be due to the occupancy of several adjacent drops. These 
observations lead to the conclusion that the DMP-PFPE emulsifying agent considerably slows 
down the kinetics of compositional ripening, but it does not suppress it totally. 
 Like DsRed, we also normalised the 4-MU fluorescence against the reference 
fluorescein, as shown in Fig. 4c, which plots the normalised intensity of 4-MU in the six 
droplets delineated in Fig. 2d. The presence of "fluorescence bursts", defined by sudden 
increases of temporal derivative, in some of the curves of Fig. 4c, is remarkable (see vertical 
arrows). Interestingly, these curves illustrate several events: 
● a full droplet with a high glucuronidase activity (drop 1), with progressive decay and 
no burst; 
● some full drops with several bursts (droplets 3 and 5); 
● a non detected full drop, for it does not show any measurable enzyme activity (droplet 
4); 
● an empty drop, indicated as a reference (droplet 6); 
● a full drop showing a low glucuronidase activity (droplet 2), that we can detect if the 
detection threshold concerns the derivative of fluorescence intensity (as seen in the inset, 
there is a burst at t=2 h). 
We can infer from Fig. 3 that this fluorescence burst at t=2 h in drop 2 cannot be attributed to 
compositional ripening, but to a true increase of glucuronidase activity. Such a sudden gain of 
enzymatic activity might be due to a daughter cell that starts its own metabolism. This 
assumption cannot be proved since we do not possess an accurate measurement of cell 
divisions within droplets. Besides, there is often a lag between bacterial division and 
metabolic activity. It may also be due to the enzyme induction of β-D-glucuronidase 15 in one 
of the encapsulated cells. 
 In order to specify a relevant detection threshold for the derivative of 4-MU 
fluorescence, we plotted the maximum of the absolute value of this derivative as a function of 
the maximum of DsRed fluorescence (Fig. 5a). In this way, we depict the maximum of 
apparent enzymatic activity as a function of bacterial growth. We decided to consider the 
absolute value of the derivative, and not the derivative itself, since we observed that some 
droplets reached their maximum enzymatic activity before t=2 h. In Fig. 5a, the empty 
droplets cluster in the lower left corner of the plot. In the lower right part of the plot, we can 
see the full droplets with bacterial growth, but without measurable enzymatic activity. By 
setting the detection threshold at 0.2 h-1 (dashed line in Fig. 5a), we are able to differentiate 
full droplets from empty ones since no empty drop reach that level. Using that threshold, we 
can plot the fraction of detected encapsulated bacteria as a function of time (Fig. 5b). More 
than half of the confined bacteria are detected in four hours and a plateau at 74% is reached 
after ten hours of incubation. As a conclusion, a quarter of the encapsulated bacteria at t=0 do 
not exhibit a detectable enzymatic activity, even after 22 hours of incubation at 37°C. Such a 
result might be explained by the fact that the MUG substrate is not the only carbon source in 
nutrition medium. 
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3.3 Enumeration methods and controls 
Stochastic confinement does not only yield a single-cell characterisation (we measured the 
heterogeneity of bacterial population), it also allows enumeration. Concerning enumeration, 
we have two types of controls: 1) pre-poured growth medium Petri dishes are inoculated at 
t=0 with the aqueous phase before emulsification, and 2) the DsRed labelling allows a control 
of the effective presence of bacteria in droplets, independent on their metabolic activity. 
 We estimated bacteria number using two methods based on DsRed labelling: 
1. We simply made the ratio between the 214 droplets exhibiting DsRed fluorescence 
and the explored volume, that is to say the total volume of the 3902 studied droplets (0.811 
µL). It yields an estimate of the concentration as 2.6×105 cfu/mL. 
2. The second estimation was based on Poisson's law and on the assumption that all the 
droplets have the same volume V=208 pL (the average volume). Since the measured 
occupancy rate is 5.48% and p(n≥1)=1-p(0)=1-e-cV, we conclude 1-e-cV=5.48×10-2. We infer 
from this equation the value of the product cV, cV=0.058, and that the concentration c equals 
2.8×105 cfu/mL. 
 The second type of control is the standard enumeration method, based on agar plates. 
We inoculated both chromID CPS3 agar plates (chromogenic medium for the enumeration 
and identification of Escherichia coli) and LB agar plates (non selective growth medium). 
CPS3 plates and LB plates yielded 1.7×105 cfu/mL and 2.0×105 cfu/mL values, respectively. 
 Similarly, our enumeration method based on enzymatic activity can also be performed 
in two ways, using the total volume of the studied droplets, or the Poissonian statistics. If we 
determine the ratio between the 158 bacteria detected after 22 hours according to the 4-MU 
fluorescence (the plateau on Fig. 5b), and the explored volume, we finally deduce c=2.0×105 
cfu/mL. These 158 detected cells reveal an occupancy rate of 4.05%. Poisson's law yields 
p(n≥1)=1-e-cV=4.05×10-2, so c=2.0×105 cfu/mL. It is important to notice that a proper 
enumeration can be done after only ten hours of incubation (Fig. 5b): if we take into account 
the number of bacteria detected at t=10 h, that is to say 155, the enumeration results are 
almost the same. As a conclusion, our enumeration method is in good agreement with the 
standard agar plate method. In contrast, the enumeration result is lower than that obtained 
with the DsRed labelling. This slight discrepancy is consistent with the lack of glucuronidase 
activity that we observed for ¼ of the encapsulated cells. 
4. Conclusions 
The aims of the present study were to determine the value of in-vitro compartmentalisation 
technique as a means to provide detection and enumeration of bacteria much faster than 
conventional methods based on bacterial growth in agar media. We showed that some bacteria 
could be detected very early (less than 2 hours) and that enumeration could be performed in 
less than 10 hours. Our technique is based on stochastic confinement of cells in pL-sized 
droplets of the sample to be analysed. Metabolic activity of single bacterial cells is then 
monitored using the fluorochrome-coupled metabolic tracer molecule MUG. Rapid 
accumulation of the fluorescent degradation product 4-MU in droplets harbouring beta-
glucuronidase-positive bacterial cells allow fast and accurate estimation of the occupancy rate 
and initial concentration of these bacteria in the sample. 
 Micro-confinement of bacteria into picoliter droplets has two benefits. First, fast 
accumulation of fluorescent tracer in occupied droplets due to micro-confinement of bacteria 
allows detection of the most active bacteria in less than 2h, while methods based on culture of 
the whole sample and bacterial growth would take much longer. Second, digital counting 
enables us to estimate more rapidly the total concentration of bacteria in the initial sample 
using stochastic repartition laws than the conventional agar plating technique. 
 10 
 By using a DsRed-labelled strain, our single-cell analysis outlined the heterogeneity of 
bacterial population and showed that ¼ of the studied bacteria are viable (since they divide), 
but do not yield detectable enzymatic activity. Nevertheless, our enumeration results, based 
on enzymatic activity, are in good agreement with conventional agar plate methods based on 
colony count. 
 Our actual efforts focus now on evaluating the dynamic range of such an alternative 
enumeration system. The major issue of compositional ripening remains unresolved and 
restricts the dynamic range by preventing storage of two filled droplets side by side. Emulsion 
formulation still requires further optimisation. In spite of this, emulsification provides a 
simple means to confine single cells in very small volumes where their metabolic activity can 
be monitored individually. A large number of droplets can be stored in a small volume 
compared with other existing confinement methods based on nebulisation and volume 
separation in micro-cuvettes. Such advantages open the way towards rapid and compact 
diagnostic systems for detection and enumeration of bacteria in contaminated sample. 
 In comparison, flow cytometry is also a rapid flow of single cells in file through a 
channel: it is faster than our method (up to 30 000 cells/s for a FACS system), and with a 
wider dynamic range (up to ~108 analysed cells). 48 However, the use of flow cytometry is not 
yet adapted to the single-cell study of metabolic processes. The technology is restricted to 
dyes that remain inside cells, and is not compatible with a kinetic study since it allows for a 
unique optical measurement. In contrast, our methodology has a significant potential for 
investigating a wide range of metabolic processes of individual bacteria or eukaryotic cells. 
By analysing the metabolites of single-cells as a function of time, it provides an insight into 
intrapopulation variability of cells and gives a quantitative analysis of population 
heterogeneity. 
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Captions 
Fig. 1 
Bacterial cell encapsulation and enzymatic assay (a) Degradation of glucuronidase substrate 
MUG (4-Methylumbelliferyl-β-D-glucuronide) into fluorescent 4-MU (4-
Methylumbelliferone). (b) Schematic of a MFFD. At the nozzle, the continuous phase 
hydrodynamically focuses the dispersed phase into a narrow channel that connects to a large 
opening: the stretching and pinching of the dispersed aqueous thread result in the formation of 
droplets. Every aqueous droplet is either empty or includes a single bacterium, provided that 
the concentration of bacteria in aqueous phase is low enough. (c) Monodisperse aqueous 
droplets can stack together into a 2D-hexagonal lattice. The maximum surface compacity of 
such an array is 91 % (pi/2√3), which means ~300 droplets/mm2. 
Fig. 2 
Example of a given field imaged at t=8 h. (a) The fluorescence of the reference fluorophore 
(fluorescein) provides with a localisation of all the droplets. (b) The fluorescence of DsRed 
protein yields a localisation of bacteria. DsRed protein does not cross cell membranes, that is 
why this fluorescence is confined in bacteria cells. At t=8 h, bacteria have already divided. (c) 
The fluorescence of 4-MU is originated from β-glucuronidase activity. 4-MU molecules 
diffuse from full droplets to empty ones because of compositional ripening. (d) Merging 
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images a (fluorescein) and b (DsRed) outlines full droplets. Here are shown the six droplets 
(five full ones and an empty one) that will be studied further in details as an example. 
Fig. 3 
Fluorescence of 4-MU between t=2 h and t=17 h, for the zone represented on Figure 2 
(scalebar : 50 µm). Droplet 6 is empty. The five other drops are full. Compositional ripening 
originates in the full droplets 1, 5 and 3: the fluorophore 4-MU diffuses from the droplets 
where it is produced to the adjacent droplets without bacteria. 
Fig. 4 
The fluorescence intensity of the different fluorophores as a function of incubation time for 
the six droplets outlined in Figure 2d. The droplets 1 to 5 are full, the 6 is empty. t=0 is the 
moment of the encapsulation of cells into microdroplets. Legend is identical in the three plots 
a, b, and c. (a) The fluorescence of the reference fluorophore (fluorescein) is constant since 
this fluorophore is not produced by bacteria. (b) The normalised fluorescence of DsRed 
protein is shown (normalised against the fluorescence of fluorescein). It generally increases 
since bacteria divide after encapsulation. Strong variations may then be observed due to depth 
field: since bacteria move inside droplets, they sometimes go out of focus, causing a decrease 
of collected fluorescence. (c) The normalised fluorescence of 4-MU is plotted. The arrows 
indicate a fluorescence burst, due to a sudden increase of enzyme activity. The inset in the top 
right corner is an enlargement of the graph in the first eight hours. 
Fig. 5 
Bacteria detection through 4-MU fluorescence measurements. (a) The maximum of the 
absolute value of the temporal derivative of normalised 4-MU fluorescence (I4MU, expressed 
in arbitrary units.h-1) is plotted against the maximum of normalised DsRed fluorescence 
(IDsRed, expressed in arbitrary units), for 184 full droplets and 128 empty droplets. 
Fluorescence intensities are normalised versus fluorescein. A threshold of 0.2 h-1 is chosen, so 
as to discriminate detected encapsulated bacteria from non-detected bacteria. (b) Fraction (%), 
among full droplets, of detected bacteria versus time. Detection is based on the 0.2 h-1 
threshold (dashed line on Figure 5a) on the derivative of 4-MU signal. A plateau is reached 
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